Peter Arlett

13PUBLICATIONS
44CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInformation systems development methodologies and practiceEpidemiological modellingDisease surveillancePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 28, 2025
A Fast Path from Innovation to Safe and Effective Medicines.

Peter Arlett, Falk Ehmann, Ralf Herold

|Oct 22, 2024
Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives.

Andrew E Beck, Melissa Kampman, Cindy Huynh

|Jul 04, 2024
Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use Cases.

Stefanie Prilla, Sophie Groeneveld, Alexandra Pacurariu

|Nov 16, 2020
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data.

Andrej Segec, Jim Slattery, Daniel R Morales

|Mar 13, 2020
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.

Jane Moseley, Spiros Vamvakas, Michael Berntgen

|Jan 20, 2020
Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee.

Robert Flynn, Karin Hedenmalm, Tarita Murray-Thomas

Pageof 3

Frequent Collaborators

4 joint publications

Xavier Kurz

3 joint publications

Patrice Verpillat

2 joint publications

Steffen Thirstrup

2 joint publications

Jim Slattery